RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 171 filers reported holding RELAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,102,500 | -33.0% | 250,000 | 0.0% | 0.02% | -32.4% |
| Q2 2023 | $3,140,000 | -30.7% | 250,000 | -9.1% | 0.04% | -40.3% |
| Q1 2023 | $4,529,250 | -8.6% | 275,000 | -17.1% | 0.06% | -6.1% |
| Q4 2022 | $4,955,045 | -33.2% | 331,663 | 0.0% | 0.07% | -36.5% |
| Q3 2022 | $7,419,000 | +33.6% | 331,663 | 0.0% | 0.10% | +20.9% |
| Q2 2022 | $5,555,000 | -44.0% | 331,663 | 0.0% | 0.09% | -46.6% |
| Q1 2022 | $9,927,000 | +26.5% | 331,663 | +29.8% | 0.16% | +43.8% |
| Q4 2021 | $7,850,000 | -2.6% | 255,601 | 0.0% | 0.11% | -15.2% |
| Q3 2021 | $8,059,000 | -23.7% | 255,601 | -11.4% | 0.13% | -33.0% |
| Q2 2021 | $10,558,000 | +28.1% | 288,557 | +21.0% | 0.20% | +7.7% |
| Q1 2021 | $8,243,000 | -32.4% | 238,440 | -18.7% | 0.18% | -43.3% |
| Q4 2020 | $12,186,000 | -18.7% | 293,215 | -16.7% | 0.32% | -34.2% |
| Q3 2020 | $14,984,000 | – | 351,823 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 6,923,574 | $58,227,257 | 6.44% |
| Finepoint Capital LP | 870,870 | $7,324,017 | 3.65% |
| Nextech Invest Ltd. | 1,196,409 | $10,061,800 | 3.05% |
| MPM BioImpact LLC | 1,352,133 | $11,371,439 | 3.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $234,680,739 | 1.93% |
| EcoR1 Capital, LLC | 4,163,824 | $35,017,760 | 1.18% |
| Integral Health Asset Management, LLC | 800,000 | $6,728,000 | 0.93% |
| Alphabet Inc. | 1,568,753 | $13,193,212 | 0.85% |
| HARBOURVEST PARTNERS LLC | 296,402 | $2,492,741 | 0.85% |
| Boxer Capital, LLC | 1,819,132 | $15,298,900 | 0.81% |